Preprint · OA
via OpenAlex
Future glucose-lowering drugs for type 2 diabetes
Clifford J. Bailey, Abd A. Tahrani, Anthony Barnett
The Lancet Diabetes & Endocrinology · 2016 · ▲ 96 citations
Abstract
This 2016 review in The Lancet Diabetes & Endocrinology examines emerging classes of glucose-lowering medications for the treatment of type 2 diabetes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/s2213-8587(15)00462-3
- Canonical
- link ↗
- Fetched
- 2026-09-02 MST
Cite this
APA
Bailey, C.J., Tahrani, A.A., & Barnett, A. (2016). Future glucose-lowering drugs for type 2 diabetes. <em>The Lancet Diabetes & Endocrinology</em>. https://doi.org/10.1016/s2213-8587(15)00462-3
Vancouver
Bailey CJ, Tahrani AA, Barnett A. Future glucose-lowering drugs for type 2 diabetes. The Lancet Diabetes & Endocrinology. 2016. doi:10.1016/s2213-8587(15)00462-3.
BibTeX
@unpublished{clifford2016Future,
title = {Future glucose-lowering drugs for type 2 diabetes},
author = {Clifford J. Bailey and Abd A. Tahrani and Anthony Barnett},
journal = {The Lancet Diabetes & Endocrinology},
year = {2016},
doi = {10.1016/s2213-8587(15)00462-3},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes Care 2004
Open access · OA
Screening for Type 2 Diabetes
Sports Medicine 1999
Citation only
Exercise and the Treatment of Type 2 Diabetes Mellitus
Physiology & Behavior 2008
Preprint · OA
Type 2 Diabetes Mellitus and Skeletal Muscle Metabolic Function
Canadian Journal of Diabetes 2013
Open access · OA
Type 2 Diabetes in Children and Adolescents
Current Diabetes Reports 2014
Citation only
PCOS in Adolescence and Type 2 Diabetes
Diabetes Research and Clinical Practice 2000
Citation only